In earlier works we have described that mice immunized with outer membrane protein OmpC survive the challenge with live Shigella flexnerii 3a. We have also identified conformational epitope of this protein, that was recognized by mice antibodies. The aim of current work was to investigate whether synthetic OmpC epitope homologs can elicit immunological response sufficient in protecting mice against shigellosis. Several linear peptides containing RYDERY motif were synthesized and conjugated to poly-lysine. These conjugates appeared to be poor immunogens and to boost the immunological response an addition of the adjuvant (MPL) was required. Unfortunately, the MPL alone caused a very high immunological reaction that was masking response to peptidic epitope. Under those circumstances we used tetanus toxoid (TT) as the carrier protein for the peptides and the agent stimulating immunological response. Series of cyclic peptides, homologs of the OmpC main epitope were synthesized and conjugated to TT. The loop size in cyclic peptides varied by number of glycine residues, i.e., 1-3 residues added to the GLNRYDERYIGK motif. The linear GLNRYDERYIGC-TT was also prepared as the control. The latter conjugate gave the highest immunological response, followed by the cyclic-GGLNRYDERYIGC-TT and cyclic-GLNRYDERYIGC-TT. The third peptide, cyclic-GGGLNRYDERYIGC-TT, gave a very low response, although it was the most resistant to proteolysis. However, antibodies obtained against cyclic-GGLNRYDERYIGC-TT were more potent to recognize both OmpC and Shigella flexnerii 3a cells than the antibodies against linear GLNRYDERYIGC-TT. Furthermore, the monoclonal antibodies raised against linear GLNRYDERYIGC-TT showed 20-fold lower dissociation constant (KD) than the naturally occurring polyclonal antibodies from umbilical cord sera. Monoclonal antibodies also gave a weaker signal in electron microscope than mice and human polyclonal antibodies. In overall, our results point to cyclic peptides as better candidates for a vaccine development, since they are eliciting production of the higher affinity antibodies against Shigella cells and OmpC.
Introduction
Shigellosis, or bacterial dysentery, caused by rod-shaped bacteria of the Shigella genus is a major health problem in the developing world. The incidence of shigellosis has been estimated at 164.7 million cases annually. More than 1 million of these cases involve children under the age of 5 years old, of which majority results in death [1] . The rise of antibiotic resistance among Shigella strains and lack of reliable and quick diagnostics limit the treatment of shigellosis and makes development of an effective vaccine an urgent issue [2, 3] . Unfortunately, there is no commercially available vaccine against shigellosis. The World Health Organization has recently given a high priority to the development of such vaccine [4] . During the last few decades various approaches, including killed whole bacterial cells, live attenuated cells and more recently subunit vaccine strategies have been investigated. So far, in clinical trials, those vaccines showed poor immunogenicity, caused side effects and the immune response was limited to particular serotypes of Shigella [5, 6] . In view of the wide range of Shigella serotypes and subtypes, there is a need for a multivalent vaccine effective for all species and serotypes. In our previous study we have shown that Shigella flexneri 3a has a 39 kDa outer membrane protein that is a very good vaccine candidate. Furthermore, this protein is quite characteristic for the Enterobacteriaceae family and may elicit immunity not only against Shigella flexneri 3a, but also against other members of this bacterial family [7] .
This protein was identified as the Outer Membrane Protein C (OmpC). It is located in the outer membrane of Shigella flexneri 3a and other members of the Enterobacteriaceae family [7] . This protein is composed of 352 amino acids forming a b-barrel structural motif [8] . Recently, the OmpC has been purified and characterized and its sequence was determined [Gene Bank: 24113600]. The three-dimensional model for OmpC from S. flexnerii 3a was built and used to predict conformational antigenic epitopes [9] . It turned out that only one of the OmpC's loops, i.e., loop V [8] that was predicted as one of five potential epitopes, was recognized by human sera. Peptide mapping of the loop V narrowed down the epitope's sequence to RYDERY [9] . The same epitope was preferentially recognized by mice sera, while a totally different epitope (loop VII), was interacting with rabbit's sera. It turns out that in mice immunized with OmpC interaction of their sera with loop V epitope can account for approx. 70% of OmpC's antigenic activity. For this reason our further studies focused on the loop V epitope.
In our earlier studies we have also shown that active immunization with purified OmpC protected mice against infection with live pathogen. Serological studies demonstrated that OmpC reacted strongly with serum from immunized mice, human normal plasma and human umbilical cord sera. The latter interaction is of special interest, considering that anti-OmpC IgGs in umbilical cord sera are transferred from mother to fetus and may play a pivotal role in protecting infants [7, 10] . The protection against S. flexneri 3a infection observed after mice vaccination with OmpC and the fact that similar antibodies are in human plasma made plausible use of the OmpC in human vaccine development.
In this work we describe the synthesis of peptides, linear and cyclic, representing OmpC epitope and their attachment to different carriers. We have also examined the peptide-carrier conjugates for their immunogenic properties, raised antibodies and examined their protective properties while infecting mice with live Shigella flexneri 3a.
Material and methods

Bacterial strain, culture conditions
Shigella flexneri serotype 3a strain (PCM 1793) used in this study was obtained from the Polish Collection of Microorganisms (PCM) of the Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences (Wroclaw, Poland). Bacteria were grown on plates with enriched Bacto Agar (Difco) and cultured for 8 h with gently shaking in liquid Brain-Heart Infusion (BHI) medium (Difco).
Animals
All experiments were carried out using 6-7 weeks old BALB/c female mice (20-25 g) purchased from the Mossakowski Institute of Experimental and Clinical Medicine of the Polish Academy of Sciences in Warsaw, Poland. Animals were held in quarantine for one week before being used in experiments. All animal studies were conducted according to the ethical guidelines of the National Ethics Committee and approved by the First Local Ethics Commission at the Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences (LKE 53/2009).
Sera
Human sera were obtained from healthy donors from the Military Center for Blood Donation, Terrain Station in Wroclaw. This study was approved by the Medical Ethics Committee of the Medical University of Wroclaw (KB-543-2014). Human umbilical cord sera from healthy women were obtained from the Obstetric Clinic of the Medical University of Wroclaw. The samples acquisition was approved by the Medical Ethics Committee of the Medical University of Wroclaw (KB-882-2012) and they were obtained with patients' written informed consent.
Isolation and purification of the OmpC from S. flexneri 3a
The outer membrane proteins (OMPs) fraction was extracted from dry bacterial mass with valeric acid following procedure described by Arcidiacono et al. [11] . The OmpC was purified from the OMPs crude fraction by gel filtration and ion-exchange chromatography as previously described [9, 10] . The fractions containing OmpC were collected, dialyzed against 0.1 M ammonium acetate, concentrated and stored at À20°C. Protein concentration was determined by Lowry method [12] .
Peptide synthesis on polyethylene pins
Peptides were synthesized using NCP Block of 96 Hydroxypropylmethacrylate pins (MIMOTOPES, Clayton, Victoria, Australia) according to the standard protocol [13] with slight modifications as described in [9] . Briefly, each pin was submersed in 100 ll of the solution containing 60 mM F-moc amino acid and equimolar amount of diisopropylcarbodiimide and N-hydroxybenzotriazole as coupling reagents for minimum 4 h. Finally, peptides were deprotected, acetylated on N-end and used for ELISA testing after disruption.
Cyclic peptides synthesis
All F-moc amino acids, solvents and reagents were purchased from Novabiochem Ò and used as recommended by the manufac- 
Stability of the cyclic and linear peptides in mice serum
Mice serum was diluted 4-fold with PBS and was centrifuged at 10 000g for 10 min to remove lipids. Peptides were mixed with diluted serum to a final concentration of 500 mM. At time intervals varied between 0 and 24 h, 5 ll samples were withdrawn and serum proteins were precipitated with 2 ll 7.5% trichloroacetic acid (TCA). After 15 min incubation at 4°C the precipitate was removed by 10 min centrifugation at 10 000g and resulting supernatant was analyzed by HPLC. To resolve intact peptides and their hydrolysis products samples were applied on Phenomenex Gemini Ò 5 µm C18 110 Å (150 Â 4.6 mm) column in 0.05% trifluoroacetic acid in water (A) -acetonitrile (B) gradient (4.7% per min) at a flow rate of 1 ml/min and at 25°C. Peaks at 13.66 and 13.88 min were attributed to cyclic GLNRYDERYIGK and linear GLNRYDERYIGKC, respectively.
Peptide protein-carrier conjugates
Prior to conjugation free amine groups on the carrier protein (tetanus toxoid, TT) were bromoacetylated in 0.1 M carbonate buffer, pH 8.3 using 1 mg N-hydroxysuccinimide bromoacetic acid ester per 1 mg of TT (0.5 ml). The tetanus toxoid sample was placed on a rotary mixer and bromoacetylated for 3 hrs at room temperature at constant pH of 8.3 that was maintained with 0.1 M NaOH. After bromoacetylation the reaction was stopped by dialysis against 0.1 M sodium bicarbonate pH 8.3 and desalted on a PD-10 column. Afterwards the protein sample was concentrated to 10-20 mg/ml and the bromoacetylation efficiency was confirmed by determining percentage of the remaining free amino groups on TT by TNBS method [14] . Briefly, peptides containing C-terminal cysteine were dissolved in 10-fold excess of methylphosphine and dried under argon in tightly closed vials. Prior to conjugation peptides were resuspended in 0.1 M carbonate buffer with 2 mM EDTA, pH 8.3 to a final concentration of 10-50 mg/ml. Bromoacetylated TT (2 mg/ml) was conjugated with peptides at the ratio of 1:50-100 (mol:mol) ratio at pH 8.5. The conjugation reaction was carried out for approx. 16 h overnight at room temperature in a sealed vial under argon using rotary shaker. The bromoacetyl groups that remained unsubstituted were inactivated with 140 mM 2-mercaptoethanol for 1 h at room temperature.
Conjugation process was monitored by SDS-PAGE in 6% polyacrylamide gel. Degree of TT substitution with peptides was estimated by MALDI-TOF-MS.
MALDI-TOF-MS analysis
The molecular mass of conjugates was measured on Bruker Ultraflex Extreme MALDI TOF/TOF mass spectrometer using flexControl software. All samples were prepared by mixing 1 ll of the conjugate (1 mg/ml) with 1 ll of saturated matrix solution, i.e. sinapinic acid resuspended in 50% ACN in 0.1% TFA. The conjugate/matrix mixture (1 ll) was spotted onto the steel plate, dried and analyzed by mass spectrometry. The spectra were analyzed by flexAnalysis (Bruker Daltonics) software.
Monoclonal antibodies
The monoclonal antibodies directed against OmpC epitope's sequence (RYDERY) were produced according to generally accepted protocol [15] . Briefly, mice were immunized with GLNRY-DERYIGC:TT conjugate as the antigen using varied doses, injection site and schedule. Firstly, mice were injected subcutaneously with 50 lg of the antigen mixed with Freund's complete adjuvant at the ratio of 1:2 (v/v). After 30 days mice were immunized intraperitoneally three times at 14-days intervals with 20 lg of the antigen mixed with incomplete Freund's adjuvant at the ratio of 1:2 (v/v). Three days before the B cell fusion, mice were given boost intraperitoneal injection of 20 lg of the antigen mixed with incomplete Freund's adjuvant. Next, B cells were isolated from mice spleen fused with cancer SP 2/0 cells and cultured for one week in RPMI 1640 medium (Sigma) supplemented with HT (Sigma). Following this step, the hybrid cells were cultured in RPMI 1640 medium supplemented with HAT (Sigma) and grown from single colonies. The hybridoma cells were screened for specific antibody production after each sub-cloning. The antibodies were screened primarily for their immunoreactivity with OmpC using direct ELISA test. Secondly, the cells were tested for their ability to recognize specific epitope sequence (RYDERY). In this case antibodies were detected by ELISA upon binding to peptide-polyethylene pins. Monoclonal antibodies were purified on ProteinA-Sepharose (Sigma).
Immunoreactivity of GLNRYDERYIGC:TT conjugate determined by dot-blot analysis
1 lg of each, peptide-TT conjugate (GLNRYDERYIGC:TT), carrier protein alone (TT, negative control) and purified OmpC (positive control), were spotted on Immobilon P membrane (Millipore). The membrane was blocked with 1% BSA in TBS-T and then incubated for 1 h at room temperature with human cord blood serum or 30 lg/ml of monoclonal antibodies in 1% BSA in TBS-T buffer (TBS-T, 20 mM Tris-HCl, pH 7.0, 50 mM NaCl, 0.05% Tween-20). After blocking step membrane was incubated for 1 h at room temperature with alkaline phosphatase-labeled goat anti-human IgG or anti-mouse IgG (Sigma) diluted 1:10 000 in TBS-T. To remove excess of the unbound AP-labeled goat antibody, membrane was washed three times with TBS for 10-15 min at each washing step. Immunoblots were developed with NBT/BCIP in 100 mM Tris-HCl, pH 9.5, with 100 mM NaCl and 50 mM MgCl 2 .
Measuring titer of the monoclonal antibodies by direct ELISA
The 96-well plates (Nunclon TM surface) were coated with 1 lg of the OmpC in carbonate buffer, pH 9.6 at 4°C overnight. Nonadsorbed antigen was removed by washing the wells three times with 200 ll of TBS-T buffer. The plate was blocked with 1% BSA (Kirkegaard & Perry Laboratories) in TBS-T buffer, pH 7.5 at room temperature for 1 h. After blocking step, all wells were washed three times using 200 ll TBS-T per well. Then each well was filled with 100 ll of the monoclonal antibody solution diluted in PBS, followed by incubation of the plates at room temperature for 1 h.
After three times wash with TBS-T, 100 ll of the AP-labeled goat anti-mouse IgG diluted 1:10 000 in PBS was added to each well. After 1 h incubation at room temperature, plates were washed with 200 ll of TBS-T and then incubated with 200 ll of APYellow (pNPP) substrate (Sigma). The reaction was stopped after 30 min with 50 ll of 3 M NaOH and absorbance at 406 nm was read on microplate reader (Biotek).
Specificity of the monoclonal antibodies
The hydroxypropylmethacrylate pins with covalently attached peptides were placed in 96-well plate in wells filled with 200 ll of 1% BSA in TBST and incubated for 1 h at room temperature. Following the blocking step pins were immersed in 100 ll of purified monoclonal antibodies and incubated again for 1 h at room temperature. Before the assay each IgG sample was diluted to 3 lg/ml with 1% BSA in TBST. After antibody binding step, pins were washed three times, each time for 5 min in 10 ml of TBS-T. To detect bound IgG, pins were incubated with goat-anti-mouse IgG-AP conjugate (Promega) diluted according to the manufacturer recommendations. The p-nitrophenyl phosphate (pNPP Liquid substrate for ELISA, Sigma) was used to measure AP activity following the manufacturer's protocol. Enzymatic reaction was stopped by removal of pins from the plate. Liberated p-nitrophenol was measured at 406 nm in a plate reader (BioTek).
Surface plasmon resonance
All experiments were performed on Biacore T-200 (GE Healthcare) using CM5 type sensor chips (GE Healthcare). The running buffer was HBS-EP (0.01 M HEPES, pH 7.4, 0.15 M NaCl, 3 mM EDTA, 0.005% Surfactant P-20). The antibodies were immobilized on the carboxymethyl dextran surface using amine-coupling chemistry. The carboxyl groups were activated for 10 min with 1:1 (v/v) mixture of 0.1 M NHS and 0.4 M EDC at a flow rate of 10 ll/min. IgG preparations isolated from human umbilical cord sera were flowed across the activated surface at concentration of 50 lg/ml and flow rate of 10 ll/min for 25 min until the maximum immobilization level (8000-11000 RU) was achieved. Any remaining activated carboxyl groups were blocked with 1 M ethanolamine, pH 8.5 for 10 min at the flow rate 10 ll/min. A similar immobilization protocol was utilized to generate a low-density surface for MAb immobilization. Lower immobilization level (400 RU) was achieved using proportionally shorter time for MAb injection. OmpC at varying concentrations was used as the analyte. The association phase was run for 180-360 s until the surface was saturated with the analyte. Next, the analyte was discontinued and dissociation phase was monitored in the presence of the running buffer. The chips were regenerated with 10 mM glycine-HCl, pH 2. The sensograms were analyzed using BIAevaluation software and the data was fitted to 1:1 Langmuir binding model.
Electron microscopy
Shigella flexneri 3a cultures were allowed to grow to stationary phase, cells were concentrated by centrifugation (10 min, at 3000 rpm) and fixed at 4°C in 4% paraformaldehyde in PBS for 18 h. Fixed cells were again centrifuged, washed 3-times with PBS and dehydrated at À20°C by gradually increasing ethanol concentration (PLT method).
Subsequently, dehydrated cells were treated with ethanolLowicryl K4M mixtures at ratios 1:1 and 1:2, and finally incubated for two days in 100% Lowicryl embedding medium. The cells suspended in Lowicryl were photopolymerized at 360 nm UV irradiation for 24 h at À20°C, followed by four days polymerization at room temperature. The thin sections were cut with diamond knife and mounted on nickel grids 400 mesh coated with formvar and carbon. Such mounted sections were subjected to immunocytochemical staining. The grids were transferred between the drops of 1% gelatin in PBS, and 0.02 M glycine in PBS. Following the blocking step, the sections were incubated overnight in a moist chamber at 4°C, first, on a drop of the antibodies, second, washed on drops of PBS and thirdly, incubated on a drop of protein A-gold 10 nm for 1 h at room temperature. In control sample antibody was omitted from the incubation. Finally, all sections were washed on drops of PBS, water and for contrasting on 2% uranyl acetate. The transmission electron microscope JEM 100 SX using 80 kV acceleration voltage was used to analyze bacterial samples. Images were registered on films. After the film development images were scanned and converted to JPEG format with Adobe Photoshop Elements 12.
Statistical analysis
Average of 4-6 samples and deviation from the mean were calculated using GraphPad Prism 6. The same program was used to prepare Figs. 1, 2, 4 and 5.
Results and discussion
Peptide-polyLys conjugates as immunogens
The mice model was used to evaluate immune response to peptide-polylysine conjugates. Sera from mice immunized with peptide conjugates (RYDERYIG-polyLys, NRYDERYIG-polyLys, LNRYDERYIG-polyLys and GLNRYDERYIG-polyLys) in mixtures with MPL adjuvant, the MPL alone, and from non-immunized with MPL adjuvant at the ratio 5:1 (v/v). Immunizations were conducted in one week intervals. Mice IgG recognizing OmpC were detected by ELISA where OmpC was absorbed to the surface of the polystyrene plate, followed by incubation with mice sera and detection with goat anti-mice IgG labeled with alkaline phosphatase (diluted 1: 10 000 in PBS). Alkaline phosphatase was detected after 1 h incubation with APYellow (pNPP) substrate (Sigma). The presented data are net immunological response obtained after subtracting signal for MPL adjuvant alone. The background constituted approx. 50% of the signal obtained for GLNRYDERYG-polyLys. animals were collected after 7 days from the last immunization. The titers of the anti-OmpC immunoglobulins in mice sera were tested by direct ELISA, where OmpC was adsorbed onto polystyrene plates (Fig. 1) . It has been noted that immune response in mice receiving peptide conjugates in MPL was comparable to the response observed in animals receiving MPL alone. Nevertheless, mice injected with GLNRYDERYIG-polyLys conjugate showed higher anti-OmpC IgG titer than mice immunized with RYDERYIG-polyLys, latter representing a minimal epitope's sequence. Therefore, peptide representing full length epitope sequence (GLNRYDERYIG) was selected for further studies. High reactivity of the OmpC with sera from mice injected with MPL alone may indicate for response induced with this adjuvant towards OmpC present in commensal bacteria of Enterobcteriaceae family, possibly caused by binding of the LPS to OmpC [16] . The MPL comprises of the detoxified lipid A portion of Salmonella minnesota LPS [17] . The MPL adjuvant might also boost non-specific immune response and cause overproduction of serum antibodies, which results in non-specific interaction with different OmpC motifs. Nonetheless, described later in this paper, MAb readily reacted with OmpC and conjugates containing OmpC epitope, but not with TT (see Fig. 6 ). The immunological activity of the sera was determined by ELISA as described in Section 2. Sera obtained from mice immunized with TT alone were used as the control. The readings obtained for the control were subtracted from all the other samples. Fig. 2 . Stability of linear and cyclic peptides in mice serum. Both GLNRYDERYIGC(l) and GGLNRYDERYIGK(c) peptides were mixed with 25% serum to final concentration of 500 mM. At time intervals ranging 0-24 h 5 ll of sample were collected, the serum proteins were precipitated with 2 ll 7,5% TCA (trichloroacetic acid) and incubated for 15 min at 4°C. After precipitation, the sample was centrifuged for 10 min at 10 000g and the resulting supernatant was analyzed by HPLC. 
Cyclic peptides
Apart from a high response by the adjuvant, peptide-polyLys conjugates gave only moderate titer anti-OmpC antibodies. To improve the odds of generating better antibodies we decided to focus on producing synthetic epitope of which conformation would better resemble the loop V in OmpC [8, 9] . Three cyclic peptides corresponding to the above mentioned loop V were synthesized, purified and their identity verified by ESI-MS analysis. The MS results are summarized in Table 1 . All cyclic peptides appeared as single HPLC peaks and for all molecular mass determined experimentally was the same as the calculated theoretical value (Table 1 ).
Stability of the peptides in mouse serum
The use of cyclic peptides in biological systems has been dictated by their two important features that makes them different from the linear ones. One is reported an increase in resistance of the cyclic peptides to proteolysis [18, 19] , and the other a diminished conformational freedom of these peptides as compared to their linear counterparts [18, 19] . Both cyclic and linear peptides were incubated with 25% mouse serum. Within minutes linear peptide was hydrolyzed (Fig. 2) , as observed by disappearance of its HPLC peak at 13.85 min. On the other hand, the cyclic peptide (GGGLNRYDERYIGC, RT = 13.43 min) retained 50% of its original concentration after 1 h incubation. Also, the hydrolysis product (RT 13.95) for the linear peptide appeared faster than the corresponding hydrolysis product for the cyclic peptide (RT = 14.56 min).
Characterization of linear and cyclic GLNRYDERYIGC derivatives conjugated to tetanus toxoid (TT)
In order to improve immunogenicity of the loop V sequence bearing peptides, they were conjugated to tetanus toxoid (TT). Both cyclic and linear GLNRYDERYIGC derivatives were synthesized and ligated to TT [20] . The electrophoretic pattern obtained after SDS-PAGE of the GLNRYDERYIGC-TT, showed similar degree of the heterogeneity as the TT alone. The chemical detoxification of the TT with formaldehyde results in such heterogeneous product (Fig. 3A) .
Our studies indicate that anti-OmpC antibodies from the umbilical cord sera recognize better a properly folded than unfolded epitope peptide. This is in agreement with defined structural features of the loop V in OmpC [8] . The series of cyclic GLNRY-DERYIGC derivatives was synthesized to assure higher resistance of this epitope to proteolysis [20] , and to stabilize its conformation by mimicking loop structure of the native epitope. Linear GLNRYDER-YIGC was applied for comparative reason.
Molecular mass of the GLNRYDERYIGC-TT conjugate (176,188 Da) and the TT-protein carrier (158,901 Da) were measured by MALDI-TOF MS (Fig. 3B) . Taking into account the molecular mass of the peptide (145,86 Da) we have determined that there were 11-12 GLNRYDERYIGC peptides conjugated to a single tetanus toxoid molecule.
Specificity of the antibodies obtained after immunization of mice with cyclic and linear peptide-TT conjugates
Mice were immunized with cyclic peptide-TT conjugates: GLNRYDERYIGC-TT(c), GGLNRYDERYIGC-TT(c), GGGLNRYDERYIGC-TT(c) and linear GLNRYDERYIGC-TT(l). The immune response was determined by ELISA with three different antigens, namely with linear GLNRYDERYIGC-TT(l) conjugate, OmpC protein and with Shigella flexneri 3a cells (Fig. 4) .
The most reactive serum was obtained when linear GLNRYDERYIGC-TT(l) conjugate was used for immunization. Three other sera also showed the highest activity towards linear GLNRY-DERYIGC conjugate. The least reactive was serum obtained after injection of the GGGLNRYDERYIGC-TT(c) conjugate, suggesting that extended loop in the cyclic peptide may have distorted this peptide's conformation (Fig. 4) . When reactivity of mice sera was measured against OmpC as the antigen, there was a substantial shift in the reactivity towards the anti-cyclic peptides sera. This trend has become even more pronounced when immunological activity was measured against Shigella flexnerii 3a cells. The most reactive were sera obtained from mice immunized with cyclic peptide-TT conjugate with two glycine residues as a linker, i.e., GGLNRYDERYIGC-TT(c). In this case serum obtained for this cyclic peptide showed higher activity than the serum produced for the linear peptide-TT conjugate. The latter results imply that cyclic peptides induce production of antibodies better recognizing native epitope's conformation on both the OmpC protein and on bacterial cell surface. On the contrary, it appears that linear peptide conjugated to TT induces antibodies primarily directed towards linear unfolded peptide. In order to prove this hypothesis monoclonal antibody were produced and used in next experiments.
Monoclonal antibody
To produce monoclonal antibodies for mice immunization we have used linear GLNRYDERYIGC-TT conjugate. After screening hybridoma cultures for antibodies recognizing Shigella cells, OmpC protein and peptides corresponding to epitope 3 sequence, monoclonal antibody directed against epitope RYDERY was obtained. This antibody was specific towards RYDERY fragment attached to polyethylene pins and it was not interacting with shorter homolog sequences (Fig. 5) .
In dot-blot test (Fig. 6A) we have observed that our monoclonal antibody interacted strongly with linear GLNRYDERYIGC-TT conjugate, but less with OmpC protein, and not at all with the TT carrier. Immunoreactivity of the MAb and antibody from umbilical cord serum were tested against OmpC and linear GLNRYDERYIGC-TT as the antigens. To remove natural serum antibodies directed against tetanus toxoid, human serum was incubated with TT, the immunoprecipitate removed and supernatant used for dotblotting. We have found that human umbilical cord serum antibodies interacted with OmpC (positive control), but only barely with GLNRYDERYIGC-TT conjugate (Fig. 6B) . Interestingly, monoclonal antibody recognized linear GLNRYDERYIGC-TT better than OmpC, while umbilical cord antibody interacted predominantly with OmpC, i.e., where epitope RYDERY is in its native loop conformation. These results are in agreement with other findings in this paper where linear peptide induced antibody interacting preferentially with linear peptide, while cyclic immunogen produced antibody recognizing loop stabilized epitope such as one present in OmpC and the surface of the bacterial cells.
Dissociation constant measured by Surface Plasmon Resonance
The differences between monoclonal and umbilical cord serum antibodies were further investigated by Surface Plasmon Resonance (BiaCore). To diminish the likelihood of the avidity effect antibodies were immobilized on the chip surface and data fitted to a simple Langmuir 1:1 interaction model. For each experiment, the data sets were fitted globally. The equilibrium binding constant was calculated individually for each antibody (KD = k d /k a ). Calculated KD, k a and k d values were summarized in Table 2 .
It is clear that MAb has lower affinity to OmpC than two polyclonal IgG preparations. The k a value was 3-5-fold lower for MAb than for polyclonal umbilical cord IgG preparations. The equilibrium constant (K D ) showed 2-4 fold difference, while the dissociation constants (k d ) were basically the same for all three samples.
Kinetic values are in agreement with the other results presented in this paper.
Testing protective properties of the anti-RYDERY MAbs in mice challenged with Shigella flexneri 3a
It is accepted in vaccine development that the best way to identify protective B cell antigen's epitope is to produce MAb against such epitope and to demonstrate that monoclonal antibodies have neutralizing and/or protective properties [21] . To evaluate protective potential of the monoclonal antibodies experiments on passive protection have been performed and results compared to effect of anti-OmpC mouse serum. Results in Table 3 show that monoclonal antibody has very low protective potential (groups 1-3), while anti-OmpC mouse serum was much better at protecting infected animals (groups 4-5). However, the best protection was achieved in mice immunized with OmpC [9] . These results corroborate published data on protective effect of the OmpC [7, 9] and corroborate our findings that low affinity monoclonal antibodies, specific for linear GLNRYDERYIGC-TT conjugate, are not suitable for protecting infected mice.
Electron microscopy
Failure of the MAb to protect mice against live pathogen was most likely caused by a weak binding of this antibody to the target protein. However, there are potential other factors that could render MAb unsuccessful, while polyclonal antibodies are effective. To investigate further differences between monoclonal and polyclonal antibodies we decided to monitor their binding to Shigella flexneri 3a cells by electron microscopy (EM). The EM images are shown on Fig. 7 . It is clear that monoclonal antibodies have fewer binding sites (Fig. 7C) at the cell's intra cellular periphery, while both mouse (Fig. 7B) and human (Fig. 7A ) polyclonal antibodies gave a much stronger signal in both surface and interior part of the cell. Whether it is essential for the antibody's protective properties to interact with both peripheral (folded), and cytoplasmic, i.e., most Determination of LD 100 : Groups of four or five mice were injected intraperitoneally with 0.2 ml of 10-fold increasing dilutions of overnight broth culture of bacteria. LD 100 for the Shigella flexneri 3a strain was calculated by the method of Reed and Muench, as described elsewhere [8] .
likely unfolded OmpC, remains debatable. However, it is possible that polyclonal antibodies, unlike MAbs, retain cross-linking properties and such feature could have been important in their therapeutic effectiveness.
Conclusions
In overall results of this work point to a cyclic peptides as a proper candidate for a vaccine, as they may elicit production of a higher affinity antibodies. Failure of the MAb to protect mice against live Shigella flexnerii 3a results probably from a poor pathogen opsonization. A weak binding and possibly inability to create larger aggregates led to MAb ineffectiveness. Synthetic cyclic peptide ensures also a better stability of the vaccine, as the construct will be less prone for serum protease digestion and thus will last longer during immunization. The immunogenicity of those cyclic peptides might be improved by using better vaccine carrier and/or adjuvant. As the cyclic epitope seems to be a good antigen, generating specific immune response against Shigella outer membrane antigen further studies on improving the immunogenicity of this peptide will be conducted.
